MLYS
NASDAQ · Biotechnology
Mineralys Therapeutics Inc
$24.63
-0.50 (-1.99%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-33.68%
1Y
+78.87%
YTD
-31.03%
Open$25.58
Previous Close$25.13
Day High$25.99
Day Low$24.52
52W High$47.65
52W Low$12.59
Volume—
Avg Volume2.21M
Market Cap2.17B
P/E Ratio—
EPS$-2.06
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$33.44
Below
SMA 200
$27.93
Below
RSI (14)
35
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
16 analysts
Price Target
+278.4% upside
Current
$24.63
$24.63
Target
$93.19
$93.19
$50.31
$93.19 avg
$121.15
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 422.84M | 383.53M | 332.94M |
| Net Income | 48.98M | 43.51M | 33.06M |
| Profit Margin | 11.6% | 11.3% | 9.9% |
| EBITDA | 63.20M | 67.45M | 57.44M |
| Free Cash Flow | 26.85M | 26.46M | 31.26M |
| Rev Growth | +5.2% | +16.0% | +2.3% |
| Debt/Equity | 0.29 | 0.28 | 0.28 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $230.01 | +6.25% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $344.72 | +2.11% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $124.87 | +0.90% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $466.79 | +3.36% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $612.50 | +0.42% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.41 | +2.99% | 64.3 | 37.13B |